Related Experiment Video
Updated: Mar 28, 2026
Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay
Published on: February 7, 2025
Applicability of the Monocyte Activation Test (MAT) for hyperimmune sera in the routine of the quality control
Cristiane Caldeira da Silva1, Octavio Augusto França Presgrave1, Thomas Hartung2
1Department of Pharmacology and Toxicology, National Institute of Quality Control in Health (INCQS), Oswaldo Cruz Foundation, Rio de Janeiro, Brazil; Centre for the Validation of Alternative Methods (BraCVAM), National Institute of Quality Control in Health (INCQS), Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Abstract:
Pyrogen tests are safety assays performed during the routine quality control of injectable products required by regulatory agencies. Currently, there are three available testing possibilities: 1) the Rabbit Pyrogen Test (RPT); 2) the Bacterial Endotoxin Test (BET); and 3) test systems using human whole-blood or monocytes, termed Monocyte Activation Test (MAT). Although BET is often considered as a replacement for the animal test, it is unable to detect pyrogens other than endotoxin. MAT is based on the human fever reaction and thus, most closely reflects the human response. The aim of this study was to conduct a parallel comparison of the RPT and MAT for hyperimmune sera (HS) batches analyzed during the routine of a quality control laboratory. MAT was performed in the same 43 batches of HS previously tested using RPT. The results showed that MAT presented 100% sensitivity and approximately 85% specificity as compared to RPT, i.e., no false-negative results were obtained. Few suspicious samples, which were negative in the RPT after retesting, provided divergent positive results suggesting a lower limit of detection of MAT. MAT is thus able to detect contaminants in biological products such as HS batches.
